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The Problem
Many compounds introduced into the
environment by human activity have the
potential to disturb the immune system of
wildlife and humans. The consequences of
such interference on the developing
immune system are not well understood.
Because of the pervasive contamination of
the environment by compounds with such
activity, a multidisciplinary group ofexperts
gathered in retreat at Wingspread, Racine,
Wisconsin, 10-12 February 1995, to assess
what is known about the issue. Participants
included experts in the fields of biology,
ecology, economy, comparative immunolo-
gy, medicine, microbiology, neurobiology,
toxicology, veterinary medicine, virology,
wildlife biology, and zoology.
The purposes ofthe meeting were a) to
reach agreement in principle on the magni-
tude and scope ofthe problem ofexposure
to synthetic chemicals on the immune sys-
tems ofwildlife and humans, with a special
emphasis on development; b) to identify
the conclusions that can be drawn with
confidence from the existing data; and c) to
establish a research agenda that wouldclarify
uncertainties that need to be addressed.
Consensus Statement
The following consensus was reached by
participants at the workshop.
This Consensus Statement is part of the Wingspread
Work Session on Chemically-induced Alterations in
the Developing Immune System: The Wildlife/Human
Connection held 10-12 February 1995 in Racine,
Wisconsin. Manuscript received 3 October 1995;
manuscript accepted 22 February 1996.
This consensus statement reflects the profession-
al wisdom of the scientists at the work session and
not necessarily the institutions or agencies in which
they are employed.
Funding for the meeting was provided by the
Charles Stewart Mott Foundation and the Keland
Endowment Fund of the Johnson Foundation.
Address correspondence to Dr. Theo Colborn,
World Wildlife Fund, 1250 Twenty-Fourth Street,
NW, Washington, DC 20037. Telephone: (202)
778-9643. Fax: (202) 530-0743. E-mail: colborn+
r%wwfus@mcimail.com
Abbreviations used: DES, diethylstilbestrol;
PCBs, polychlorinated biphenyls.
a) We are certain ofthe following-
A competent immune system is essential
for health.
Experimental lab studies demonstrate
that certain synthetic chemicals affect the
immune system (e.g., aromatic hydrocar-
bons; carbamates; heavy metals; organo-
halogens; organophosphates; organotins;
oxidant air pollutants, such as ozone and
nitrogen dioxide; and polycyclic aromatic
hydrocarbons). These effects are manifested
as alterations in the immune system that
may lead to a decreased quality oflife. These
alterations include immune modulation
expressed as an increase or decrease in mea-
sured immune parameters, hypersensitivity,
and autoimmunity.
Changes in the characteristics of the
immune system in humans and certain
wildlife species have been associated with
both therapeutic and environmental expo-
sure to synthetic chemicals, e.g., diethyl-
stilbestrol (DES), dioxin, polychlorinated
biphenyls (PCBs).
Impairment of the immune system can
result from alterations in the development
of the immune system and may be long-
lasting. The effects may not be manifested
at hatching or birth and may not be
expressed until the animal or human reach-
es adulthood.
Life-long capacity for immune response
is determined early in development,
during prenatal and early postnatal devel-
opment in mammals and prehatching
and early posthatching development in
egg-laying species.
Alterations in the developing and
mature immune systems may not be recog-
nized as an adverse health effect until long
after the exposure.
Some wildlife and human populations
are exposed to elevated levels of certain
synthetic chemicals.
The widespread exposure ofpopulations
ofhumans and wildlife to many man-made
chemicals has made it difficult, if not
impossible, to find control populations
that have no exposure level. True control
populations for human and wildlife
epidemiological studies are thus lacking.
b) We estimate with confidence that-
Certain synthetic chemicals, such as
those listed above, released or reintroduced
into the environment act upon the devel-
oping and mature immune systems in
humans and other vertebrates.
Prenatal and early postnatal mammals
and the immature and early life stages of
amphibians, reptiles, fishes, and birds are
likely to be the most vulnerable life stages
to immunomodulation.
Vulnerability upon exposure varies
among gender, species, and stages of the
life cycle. In addition to embryos, fetuses,
and the newborn, children, the very old,
and certain populations (e.g., chronically
ill, poorly nourished, HIV positive) are
also likely to be more at risk.
In certain instances, humans and
wildlife are experiencing immune alter-
ations. Data suggest that immune alter-
ations seen in wild animals and humans are
consistent with those produced by synthet-
ic chemicals identified as immunotoxic in
studies with laboratory animals.
Immunotoxic effects expressed in indi-
viduals could therefore be expressed at the
population level thus affecting biodiversity
at the community or ecosystem level.
Immune system effects reported in
wildlife, in parallel with in vitro and in vivo
experimental studies, support the possibility
for qualitative prediction ofhuman effects.
Current predictive capability for
immunomodulation is limited to iden-
tification of qualitative changes not quan-
titative changes.
c) Based on our current understanding
we predict-
Certain synthetic chemicals can cause
alterations of the developing immune
system.
Alterations in immunologic function
whether occurring prenatally or embry-
ologically or later in life can translate into
altered host resistance and susceptibility to
disease, including autoimmune disease.
Disease patterns are thus likely to be affect-
ed by immune modulation induced by
immunological toxicants.
d) There are uncertainties in our
understanding because-
More needs to be learned about how
the immune system develops.
Few well-controlled human or wildlife
ecoepidemiological studies that document
immune modulation have been completed.
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The lack of sensitive tests and the uncer-
tainty about exposure have been impedi-
ments in many ofthese studies. Exposure is
well known for somewildlife studies.
Information on exposure is limited.
Little is known about the effects of long-
term, low-level exposure.
Little is known about the effects of
exposure to chemical mixtures. Most pub-
lished studies use single agents when testing
for the effects of environmental exposure.
The specific components of environmental
mixtures are rarely defined.
The pharmacokinetics of many immu-
notoxic compounds in target organs is
understood in experimental animals but
not in humans and wildlife.
Data are lacking about the persistence
ofthe effects ofimmunomodulators.
For regulatory purposes, the current lack
of knowledge about the mechanisms lead-
ing to immunomodulation makes cause-
and-effect linkages extremely difficult.
Uncertainty exists about whether the
right questions have been asked concerning
the mechanisms ofimmune modulation.
e) Ourjudgment is that-
The potential exists for widespread
immunotoxicity in humans and wildlife
species because of the worldwide lack of
appropriate protective standards. This is
based on documented immune effects from
high-level exposure, plus a large amount of
anecdotal data on humans and wildlife,
and strong experimental animal data.
Although exposure is widespread, it
varies from region to region and individual
to individual. Based on anecdotal informa-
tion, it is presumed that exposure is greater
in Eastern Europe and the former Soviet
Union and especially in developing countries
because of lack of adequate environmental
regulations and enforcement.
The lack ofhuman epidemiological stud-
ies in the developingworld makes it impossi-
ble to determine the scale ofimmune modu-
lation and/or autoimmune disease among
these populations. The consequences of
chemical exposure in developing countries
may be severe because of multiple con-
founders such as poverty, malnutrition, and
poor medical care. The consequences will be
difficult to identify because of the lack of
adequate control cohorts.
The risk of exposure to known immu-
nomodulators is sufficient to warrant
regulatory approaches that would limit
exposure.
f)To improve our predictive capacity-
More basic research is needed on the
development of the immune system of
diverse animal species and the factors that
drive its maturation and senescence.
Further study is needed to understand the
mechanistic role of synthetic chemicals in
the alteration ofthese processes.
Priority needs to be given to developing
assays predictive of disease resistance for a
variety of species. It is important to know
how immune modulation affects increased
prevalence of infectious diseases among
humans and wildlife.
More emphasis must be placed on
developmental immunotoxicology. This
can be accomplished through collaborative
research efforts to standardize protocols,
share specimens, and to develop inexpen-
sive, rapid, biomarkers of immunotoxicity.
The use of the Internet and other online
systems to apprise researchers of planned
and ongoing experiments will increase
collaborative opportunities.
Models based on "real world" situations
(dose, duration of exposure, timing) that
include metabolism, pharmacokinetics,
route of exposure, and target effects in a
number of indicator species should be
developed for extrapolation to humans and
other species.
Ecoepidemiological criteria that include
dose-response, time order (exposure pre-
cedes effect), specificity, strength ofassoci-
ation, coherence, and predictability com-
bined with laboratory validation are need-
ed to improve the level ofcertainty in epi-
demiological studies.
More epidemiological research among
susceptible populations, especially in
developing countries, is needed.
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